Physiomics PLC
LSE:PYC

Watchlist Manager
Physiomics PLC Logo
Physiomics PLC
LSE:PYC
Watchlist
Price: 0.285 GBX Market Closed
Market Cap: 864.1k GBX

Net Margin
Physiomics PLC

-53%
Current
-74%
Average
1.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-53%
=
Net Income
-415.3k
/
Revenue
784k

Net Margin Across Competitors

No Stocks Found

Physiomics PLC
Glance View

Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. The company is headquartered in Oxford, Oxfordshire and currently employs 7 full-time employees. The company went IPO on 2004-12-20. The firm offer Virtual Tumour technology and other tools to predict the effects of cancer treatments. The Company’s Virtual Tumour software platform is used to simulate the effects of anti-cancer agents on pre-clinical and human tumors. The company is used by companies ranging from startup biotech to global large-cap pharmaceuticals. The firm provides a range of Pharmacokinetic/Pharmacodynamics (PK/PD) services, usually in support of smaller companies where this function is outsourced. The Company’s services include oncology specialists, mechanistic modelling, PK/PD, quantitative systems pharmacology and mathematical modelling.

PYC Intrinsic Value
0.613 GBX
Undervaluation 54%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-53%
=
Net Income
-415.3k
/
Revenue
784k
What is the Net Margin of Physiomics PLC?

Based on Physiomics PLC's most recent financial statements, the company has Net Margin of -53%.

Back to Top